PNC Financial Services Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.23M | Buy |
|
|||||
|
2025
Q2 | $974K | Buy |
|
|||||
|
2025
Q1 | $1.51M | Buy |
|
|||||
|
2024
Q4 | $534K | Sell |
|
|||||
|
2024
Q3 | $493K | Sell |
|
|||||
|
2024
Q2 | $353K | Buy |
|
|||||
|
2024
Q1 | $272K | Sell |
|
|||||
|
2023
Q4 | $358K | Buy |
|
|||||
|
2023
Q3 | $234K | Sell |
|
|||||
|
2023
Q2 | $194K | Buy |
|
|||||
|
2023
Q1 | $167K | Sell |
|
|||||
|
2022
Q4 | $186K | Buy |
|
|||||
|
2022
Q3 | $228K | Buy |
|
|||||
|
2022
Q2 | $168K | Buy |
|
|||||
|
2022
Q1 | $154K | Buy |
|
|||||
|
2021
Q4 | $126K | Sell |
|
|||||
|
2021
Q3 | $139K | Buy |
|
|||||
|
2021
Q2 | $133K | Sell |
|
|||||
|
2021
Q1 | $158K | Buy |
|
|||||
|
2020
Q4 | $170K | Buy |
|
|||||
|
2020
Q3 | $105K | Sell |
|
|||||
|
2020
Q2 | $105K | Buy |
|
|||||
|
2020
Q1 | $70K | Sell |
|
|||||
|
2019
Q4 | $106K | Sell |
|
|||||
|
2019
Q3 | $1.77M | Sell |
|
|||||
|
2019
Q2 | $1.81M | Sell |
|
|||||
|
2019
Q1 | $2.47M | Sell |
|
|||||
|
2018
Q4 | $6.2M | Buy |
|
|||||
|
2018
Q3 | $104K | Sell |
|
|||||
|
2018
Q2 | $1.18M | Buy |
|
|||||
|
2018
Q1 | $1.19M | Sell |
|
|||||
|
2017
Q4 | $5.15M | Sell |
|
|||||
|
2017
Q3 | $5.89M | Buy |
|
|||||
|
2017
Q2 | $116K | Buy |
|
|||||
|
2017
Q1 | $72K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $2K | Buy |
|
|||||
|
2015
Q4 | $2K | Hold |
|
|||||
|
2015
Q3 | $2K | Buy |
|
|||||
|
2015
Q2 | $3K | Buy |
|
|||||
|
2015
Q1 | $2K | Buy |
|